News & Publications

OCG is committed to sharing its research with the community. Stay informed by reading the latest news & publications and subscribing to the OCG e-Newsletter.

Publications

Ovarian Cancer Stage IIIA
CTD²
Molecular Cancer Therapeutics

Ovarian clear cell carcinoma (OCCC) is a rare, chemo-resistant subtype of ovarian cancer. To identify novel therapeutic targets and combination therapies for OCCC, we subjected a set of patient-derived ovarian cancer cell lines to arrayed high throughput siRNA and drug screening. The results...

DNA methylation patterns are stable at relapse except in a minority of cases.
CTD²
Genome Research

Acute myeloid leukemia (AML) is a molecularly complex disease characterized by heterogeneous tumor genetic profiles and involving numerous pathogenic mechanisms and pathways. Integration of molecular data types across multiple patient cohorts may advance current genetic approaches for improved...

e-Newsletter

Issue 25, February, 2021

HCMI Program Highlights

HCMI organoid banner image
Eva Tonsing-Carter, Ph.D. and Cindy Kyi, Ph.D.
Last updated: April 13, 2021